Long-Acting Reversible Contraception in Primary Care: A Cross-Sectional Study on the Perspectives of Portuguese Family Physicians
DOI:
https://doi.org/10.20344/amp.24370Keywords:
Long-Acting Reversible Contraception, Portugal, Primary Health CareAbstract
Long-acting reversible contraceptives (LARC) are recommended as first-line methods due to high efficacy and safety. Family Medicine (FM) physicians are ideally positioned to provide counseling and LARC-related services; however, their implementation in primary care is hindered by multiple constraints. The aim of this nationwide cross-sectional study was to characterize family planning practices among FM physicians in Portugal, to identify the main obstacles to LARC provision, and to propose strategies to enhance clinical autonomy. In this manner, an anonymous online questionnaire was distributed among FM physicians (specialists and residents), currently working within the Portuguese National Health Service. A total of 220 responses were collected over six weeks. While nearly all physicians (99.5%) routinely conducted family planning consultations, only 31.8% of respondents reported feeling fully prepared to perform LARC insertions autonomously. Among those who rarely insert LARC (18.7%), the main barriers identified were related to organizational constraints (38.0%) and gaps in practical training (37.0%). The majority (98.2%) expressed interest in further training, particularly in practical insertion/removal techniques. In conclusion, this study highlighted a significant gap in confidence among Portuguese FM physicians regarding LARC provision. Strengthening simulation-based training and promoting structured mentorship with gynecology specialists may help overcome these barriers.
Downloads
References
World Health Organization. Medical eligibility criteria for contraceptive use. 5th ed. Geneva: WHO; 2015.
Direção-Geral da Saúde. Norma n.º 016/2012: planeamento familiar e saúde reprodutiva. Lisboa: DGS; 2022.
American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No. 186: long-acting reversible contraception: implants and intrauterine devices. Obstet Gynecol. 2017;130:e251-69. DOI: https://doi.org/10.1097/AOG.0000000000002400
Baker CC, Creinin MD. Long-acting reversible contraception. Obstet Gynecol. 2022;140:883-97. DOI: https://doi.org/10.1097/AOG.0000000000004967
Holt K, Reed R, Crear-Perry J, Scott C, Wulf D, Dehlendorf C. Beyond same-day long-acting reversible contraception: a paradigm shift to equitable access for all. Contraception. 2024;125:110907.
Linton E, Mawson R, Hodges V, Mitchell CA. Understanding barriers to using long-acting reversible contraceptives (LARCs) in primary care: a qualitative evidence synthesis. BMJ Sex Reprod Health. 2023;49:282-92. DOI: https://doi.org/10.1136/bmjsrh-2022-201560
Mazza D, Bateson D, Frearson M, Goldstone P, Kovacs G, Baber R. Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion. Aust N Z J Obstet Gynaecol. 2017;57:206-212. DOI: https://doi.org/10.1111/ajo.12587
European Parliamentary Forum for Sexual & Reproductive Rights. European Contraception Policy Atlas 2025. Brussels: EPF; 2025.
Olson EM, Kramer RD, Gibson C, Wautlet CK, Schmuhl NB, Ehrenthal DB. Health care barriers to provision of long-acting reversible contraception in Wisconsin. WMJ. 2018;117:149-55.
Olson EM, Kramer RD, Gibson C, Wautlet CK, Schmuhl NB, Ehrenthal DB. Health care barriers to provision of long-acting reversible contraception in Wisconsin. WMJ. 2018;117:149-55.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.
